[1] Lewis GN, Byblow WD, Walt SE.Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues[J]. Brain, 2000, 123( Pt 10):2077-2090. [2] Visser JE, Oude Nijhuis LB, Janssen L, et al.Dynamic posturography in Parkinson's disease: diagnostic utility of the "first trial effect"[J]. Neuroscience, 2010, 168(2):387-394. [3] Ayton S, George JL, Adlard PA, et al.The effect of dopamine on MPTP-induced rotarod disability[J]. Neurosci Lett, 2013, 543:105-109. [4] Liu SM, Li XZ, Huo Y, et al.Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice[J]. Phytomedicine, 2012,19(7):631-638. [5] Deumens R, Jaken RJ, Marcus MA, at al. The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection[J]. J Neurosci Methods, 2007, 164(1):120-130. [6] Ma KL, Gao JH, Huang ZQ, et al.Motor function in MPTP-treated tree shrews (Tupaia belangeri chinensis)[J]. Neurochem Res, 2013, 38(9):1925-1940. [7] Lambert CE, Bondy SC.Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress[J]. Life Sci, 1989, 44(18):1277-1284. [8] Athauda D, Foltynie T.The ongoing pursuit of neuroprotective therapies in Parkinson disease[J]. Nat Rev Neurol, 2015, 11(1):25-40. [9] McCormack AL, Mak SK, Shenasa M, et al. Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys[J]. J Neuropathol Exp Neurol, 2008, 67(8):793-802. [10] 徐林, 张云, 梁斌, 等. 实验动物树鼩和人类疾病的树鼩模型研究概述[J]. 动物学研究, 2013, 34(2):59-69. [11] 代解杰, 罕园园, 孙晓梅. 我是树鼩, 你知道我么?[J]. 中国比较医学杂志, 2015, 25(11):90-91. [12] Kim ST, Son HJ, Choi JH, et al.Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease[J]. Brain Res, 2010, 1306:176-183. [13] Wang XH, Lu G, Hu X, et al.Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease[J]. BMC Neurosci, 2012, 13(1):142. [14] 王军, 张旺明, 罗敏捷, 等. 6-羟基多巴胺致帕金森病模型大鼠步态的CatWalk定量分析[J]. 中华神经医学杂志, 2012, 11(4):364-368. [15] Kalia LV, Lang AE.Parkinson's disease[J]. Lancet, 2015, 386(9996):896-912. [16] 杨谦谦, 孙芳龄, 艾厚喜, 等. 6-羟多巴胺诱导帕金森病大鼠模型行为学评价方法的探讨[J]. 神经药理学报, 2013, 3(1):17-22. [17] Morris ME, Iansek R, Matyas TA, et al.Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms[J]. Brain, 1996, 119(Pt2):551-568. [18] 陈永平, 商慧芳. 2016中国帕金森病诊断标准解读[J]. 中国实用内科杂志, 2017, 37(2):124-126. [19] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49(4):268-271. [20] Goetz CG, Stebbins GT, Chmura TA, et al.Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale: (MDS-UPDRS)[J]. Mov Disord, 2010, 25(9):1190-1194. |